Dynavax Announces Fourth Quarter and Full Year 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Dynavax Technologies (DVAX) PT Lowered to $23 at RBC Capital
February 27, 2019 6:50 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Dynavax Technologies (NASDAQ: DVAX) to $23.00 (from $25.00) while maintaining a Outperform rating.
... MoreDynavax (DVAX) Misses Q4 EPS by 3c
February 26, 2019 4:36 PM ESTDynavax (NASDAQ: DVAX) reported Q4 EPS of ($0.64), $0.03 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $3.43 million.
Cash, cash equivalents and marketable securities totaled $145.5 million at December 31, 2018, compared to $191.9 million at December 31, 2017. Dynavax plans to borrow $75.0 million under its non-dilutive term loan agreement in the... More
